Other recent research found that cerebral rSO2 monitoring provides a first alert to changes in oxygenation that could potentially lead to an adverse patient outcome. Cerebral oximetry data, such as that from the INVOS System, were registered from January 2008 through December 2009 in the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database, which is the gold standard for specialty outcomes databases. Initial findings were released in July 2010 and showed that in nearly one in four (23%) cardiac surgery procedures (n=36,548) "cerebral oximetry provided the first indication of a technical problem or physiologic change that could potentially lead to an adverse patient outcome."2
"Oxygen deficiencies that lead to neurological injury or other complications often have no initial outward signs; they can brew silently and go undetected until damage has already been done," Dr. Kelley continued. "Use of preoperative rSO2 could augment anesthesiologists' already robust practices for vigilance and patient safety."
Ad Statistics
Times Displayed: 114615
Times Visited: 6802 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About Covidien
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Back to HCB News
